News
Japan’s Yoshinori Ohsumi wins Nobel for studies of cell ‘self-eating’
Japanese scientist whose experiments explored the machinery by which cells recycle their dilapidated or unwanted contents won the Nobel Prize in physiology or medicine on Monday. Yoshinori Ohsumi, a 71-year-old biologist at the Tokyo Institute of...
News
Sartorius Stedim Biotech launches two Single-use Sartocon Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced its polyethersulfone membrane (PESU) is now integrated into two new, sterile Sartoconยฎ benchtop and production scale filtration assemblies. Using these assemblies guarantees rapid and safe ultrafiltration...
News
Zuellig Pharma to distribute imdur in eight markets for Topridge Pharma
Zuellig Pharma and TopRidge Pharma Limited have signed a deal that will see Zuellig Pharma distribute Imdur, a mature medicine for the prevention of angina in patients with heart disease, in eight markets across the region. ...
News
Amgen To Present At The Morgan Stanley Global Healthcare Conference
Amgen will present at the Morgan Stanley Global Healthcare Conference at 10:30 a.m. ET on Wednesday, Sept. 14, 2016, in New York City. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. ...
News
Teva to Present at the Wells Fargo 2016 Healthcare Conference
Teva Pharmaceutical Industries Ltd will host a live audio webcast at the Wells Fargo Healthcare Conference. Eyal Desheh will present on Wednesday, September 7, 2016 at 1:10 PM ET. What:ย Teva Presentation at the Wells Fargo 2016...
News
Teva to Host Generic Medicines Business Overview on September 9, 2016
Teva Pharmaceutical Industries Ltd. announced that it will host a conference call and live webcast along with a slide presentation on Friday, September 9, 2016 at 8:00 a.m. ET to communicate an overview of the future prospects of Teva...
News
TG Therapeutics Announces TG-1101 for the Treatment of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder
TG Therapeutics, Inc. announced that the U.S. FDA has granted orphan drug designation for TG-1101 (ublituximab) the Companyโs novel, glycoengineered anti-CD20 monoclonal antibody, for the treatment of patients with neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















